Rapidly developing resistance against different therapeutics is a major stumbling block in the standardization of therapy. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated signaling has emerged as one of the most highly and extensively studied signal transduction cascade that induces apoptosis in cancer cells. Rapidly emerging cutting-edge research has helped us to develop a better understanding of the signaling machinery involved in inducing apoptotic cell death. However, excitingly, cancer cells develop resistance against TRAIL-induced apoptosis through different modes. Loss of cell surface expression of TRAIL receptors and imbalance of stoichiometric ratios of pro- and anti-apoptotic proteins play instrumental roles in rewiring the machinery of cancer cells to develop resistance against TRAIL-based therapeutics. Natural products have shown excellent potential to restore apoptosis in TRAIL-resistant cancer cell lines and in mice xenografted with TRAIL-resistant cancer cells. Significantly refined information has previously been added and continues to enrich the existing pool of knowledge related to the natural-product-mediated upregulation of death receptors, rebalancing of pro- and anti-apoptotic proteins in different cancers. In this mini review, we will set spotlight on the most recently published high-impact research related to underlying mechanisms of TRAIL resistance and how these deregulations can be targeted by natural products to restore TRAIL-mediated apoptosis in different cancers. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.
Yazar |
Shahwar, D. Iqbal, M.J. Nisa, M.-U. Todorovska, M. Attar, Rukset Sabitaliyevich, U.Y. Xu, B. |
Yayın Türü | Review |
Tek Biçim Adres | https://hdl.handle.net/20.500.11831/2974 |
Konu Başlıkları |
Apoptosis
Cancer Death receptors Natural products TRAIL |
Koleksiyonlar |
Araştırma Çıktıları | Ön Baskı | WoS | Scopus | TR-Dizin | PubMed 02- WoS İndeksli Yayınlar Koleksiyonu 03- Scopus İndeksli Yayınlar Koleksiyonu 05- PubMed İndeksli Yayınlar Koleksiyonu |
Dergi Adı | International Journal of Molecular Sciences |
Cild | 20 |
Dergi Sayısı | 8 |
Sayfalar | - |
Yayın Tarihi | 2019 |
Eser Adı [dc.title] | Natural product mediated regulation of death receptors and intracellular machinery: Fresh from the pipeline about TRAIL-mediated signaling and natural TRAIL sensitizers |
Yazar [dc.contributor.author] | Shahwar, D. |
Yazar [dc.contributor.author] | Iqbal, M.J. |
Yazar [dc.contributor.author] | Nisa, M.-U. |
Yazar [dc.contributor.author] | Todorovska, M. |
Yazar [dc.contributor.author] | Attar, Rukset |
Yazar [dc.contributor.author] | Sabitaliyevich, U.Y. |
Yazar [dc.contributor.author] | Xu, B. |
Yayıncı [dc.publisher] | MDPI AG |
Yayın Türü [dc.type] | review |
Özet [dc.description.abstract] | Rapidly developing resistance against different therapeutics is a major stumbling block in the standardization of therapy. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated signaling has emerged as one of the most highly and extensively studied signal transduction cascade that induces apoptosis in cancer cells. Rapidly emerging cutting-edge research has helped us to develop a better understanding of the signaling machinery involved in inducing apoptotic cell death. However, excitingly, cancer cells develop resistance against TRAIL-induced apoptosis through different modes. Loss of cell surface expression of TRAIL receptors and imbalance of stoichiometric ratios of pro- and anti-apoptotic proteins play instrumental roles in rewiring the machinery of cancer cells to develop resistance against TRAIL-based therapeutics. Natural products have shown excellent potential to restore apoptosis in TRAIL-resistant cancer cell lines and in mice xenografted with TRAIL-resistant cancer cells. Significantly refined information has previously been added and continues to enrich the existing pool of knowledge related to the natural-product-mediated upregulation of death receptors, rebalancing of pro- and anti-apoptotic proteins in different cancers. In this mini review, we will set spotlight on the most recently published high-impact research related to underlying mechanisms of TRAIL resistance and how these deregulations can be targeted by natural products to restore TRAIL-mediated apoptosis in different cancers. © 2019 by the authors. Licensee MDPI, Basel, Switzerland. |
Kayıt Giriş Tarihi [dc.date.accessioned] | 2020-03-17 |
Yayın Tarihi [dc.date.issued] | 2019 |
Açık Erişim Tarihi [dc.date.available] | 2020-03-17 |
Dil [dc.language.iso] | eng |
Konu Başlıkları [dc.subject] | Apoptosis |
Konu Başlıkları [dc.subject] | Cancer |
Konu Başlıkları [dc.subject] | Death receptors |
Konu Başlıkları [dc.subject] | Natural products |
Konu Başlıkları [dc.subject] | TRAIL |
Haklar [dc.rights] | info:eu-repo/semantics/openAccess |
ISSN [dc.identifier.issn] | 16616596 |
Dergi Adı [dc.relation.journal] | International Journal of Molecular Sciences |
Dergi Sayısı [dc.identifier.issue] | 8 |
Cild [dc.identifier.volume] | 20 |
Tek Biçim Adres [dc.identifier.uri] | https://hdl.handle.net/20.500.11831/2974 |